Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2008 1
2009 1
2010 3
2011 2
2012 5
2013 5
2014 3
2015 1
2021 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial.
Diletti R, den Dekker WK, Bennett J, Schotborgh CE, van der Schaaf R, Sabaté M, Moreno R, Ameloot K, van Bommel R, Forlani D, van Reet B, Esposito G, Dirksen MT, Ruifrok WPT, Everaert BRC, Van Mieghem C, Elscot JJ, Cummins P, Lenzen M, Brugaletta S, Boersma E, Van Mieghem NM; BIOVASC Investigators. Diletti R, et al. Among authors: ruifrok wpt. Lancet. 2023 Apr 8;401(10383):1172-1182. doi: 10.1016/S0140-6736(23)00351-3. Epub 2023 Mar 5. Lancet. 2023. PMID: 36889333 Clinical Trial.
Erythropoiesis stimulation in acute ischemic syndromes.
Ruifrok WP, Lipsic E, de Boer RA, van Gilst WH, van Veldhuisen DJ. Ruifrok WP, et al. Heart Fail Clin. 2010 Jul;6(3):313-21. doi: 10.1016/j.hfc.2009.12.002. Heart Fail Clin. 2010. PMID: 20630406 Review.
Erythropoietin in cardiac disease: new features of an old drug.
Ruifrok WP, de Boer RA, Westenbrink BD, van Veldhuisen DJ, van Gilst WH. Ruifrok WP, et al. Eur J Pharmacol. 2008 May 13;585(2-3):270-7. doi: 10.1016/j.ejphar.2008.01.054. Epub 2008 Mar 15. Eur J Pharmacol. 2008. PMID: 18407263 Review.
Galectin-3 increase in endurance athletes.
Hättasch R, Spethmann S, de Boer RA, Ruifrok WP, Schattke S, Wagner M, Schroeckh S, Durmus T, Schimke I, Sanad W, Baumann G, Borges AC, Knebel F. Hättasch R, et al. Among authors: ruifrok wp. Eur J Prev Cardiol. 2014 Oct;21(10):1192-9. doi: 10.1177/2047487313492069. Epub 2013 May 30. Eur J Prev Cardiol. 2014. PMID: 23723328
Pharmacological inhibition of galectin-3 protects against hypertensive nephropathy.
Frenay AR, Yu L, van der Velde AR, Vreeswijk-Baudoin I, López-Andrés N, van Goor H, Silljé HH, Ruifrok WP, de Boer RA. Frenay AR, et al. Among authors: ruifrok wp. Am J Physiol Renal Physiol. 2015 Mar 1;308(5):F500-9. doi: 10.1152/ajprenal.00461.2014. Epub 2014 Dec 10. Am J Physiol Renal Physiol. 2015. PMID: 25503732 Free article.
The erythropoietin receptor expressed in skeletal muscle is essential for mitochondrial biogenesis and physiological exercise.
Nijholt KT, Meems LMG, Ruifrok WPT, Maass AH, Yurista SR, Pavez-Giani MG, Mahmoud B, Wolters AHG, van Veldhuisen DJ, van Gilst WH, Silljé HHW, de Boer RA, Westenbrink BD. Nijholt KT, et al. Among authors: ruifrok wpt. Pflugers Arch. 2021 Aug;473(8):1301-1313. doi: 10.1007/s00424-021-02577-4. Epub 2021 Jun 17. Pflugers Arch. 2021. PMID: 34142210 Free PMC article.
Timing of Complete Multivessel Revascularization in Patients Presenting With Non-ST-Segment Elevation Acute Coronary Syndrome.
Elscot JJ, Kakar H, Scarparo P, den Dekker WK, Bennett J, Schotborgh CE, van der Schaaf R, Sabaté M, Moreno R, Ameloot K, van Bommel RJ, Forlani D, Van Reet B, Esposito G, Dirksen MT, Ruifrok WPT, Everaert BRC, Van Mieghem C, Pinar E, Alfonso F, Cummins P, Lenzen M, Brugaletta S, Daemen J, Boersma E, Van Mieghem NM, Diletti R; BIOVASC Investigators. Elscot JJ, et al. Among authors: ruifrok wpt. JACC Cardiovasc Interv. 2024 Mar 25;17(6):771-782. doi: 10.1016/j.jcin.2024.01.278. JACC Cardiovasc Interv. 2024. PMID: 38538172 Free article. Clinical Trial.
21 results